Evidence map›Paper›PMID 35775404›Full record

ArticleTurkish journal of pharmaceutical sciences2022

Evaluation of Marketed Almond Oils [

Aysel Berkkan, Berra Nur Dede Türk, Sultan Pekacar, Onur Kenan Ulutaş, Didem Deliorman Orhan

Abstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Evaluation of Marketed Rosemary Essential Oils (Turkish journal of pharmaceutical sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aysel BerkkanGazi University, Faculty of Pharmacy, Department of Analytical Chemistry, Ankara, Türkiye.ORCID 0000-0003-4669-5496
Berra Nur Dede TürkGazi University, Faculty of Pharmacy, Department of Pharmacognosy, Ankara, Türkiye.ORCID 0000-0002-7117-4310
Sultan PekacarGazi University, Faculty of Pharmacy, Department of Pharmacognosy, Ankara, Türkiye.ORCID 0000-0002-7782-9832
Onur Kenan UlutaşGazi University, Faculty of Pharmacy, Department of Toxicology, Ankara, Türkiye.ORCID 0000-0001-8819-9461
Didem Deliorman OrhanGazi University, Faculty of Pharmacy, Department of Pharmacognosy, Ankara, Türkiye.ORCID 0000-0003-3916-4048

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Almond oil marketed for health benefits and cosmetic purposes should be in compliance with the European Pharmacopoeia (EP) criteria. Therefore, in this study, 17 almond oil samples sold in pharmacies, herbal shops, online, and cosmetics stores were analyzed in terms of "almond oil" monograph criteria, which have been mentioned in EP 7.0. Materials and Methods: In this study, 17 almond oil samples sold in pharmacies, herbal, online, and cosmetics stores were analyzed in terms of "almond oil" monograph criteria, which have been mentioned in EP 7.0. Appearance, acidity value, and peroxide value of each sample were determined and the ingredients were identified by thin layer chromatography. Fatty acids were analyzed by gas chromatographic method using flame ionization detector. Results: It was determined that two of the 17 samples complied with EP 7.0 criteria. Conclusion: Almond oil, which is currently marketed according to the manufacturer's own marketing and quality criteria, is excluded from the Turkish Food Codex Standards. Our research has shown that most of the products do not comply with the EP standards. For this reason, it should be ensured that almond oil is listed in this codex and urgent arrangements should be made for quality control analysis.

Indexed as

Fatty acidsgas chromatography-mass spectrometryPrunus dulcisquality control

Identifiers

PMID35775404
PMCPMC9254091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.